DK357185A - Fremgangsmaade til diagnosticering af cancer - Google Patents

Fremgangsmaade til diagnosticering af cancer Download PDF

Info

Publication number
DK357185A
DK357185A DK357185A DK357185A DK357185A DK 357185 A DK357185 A DK 357185A DK 357185 A DK357185 A DK 357185A DK 357185 A DK357185 A DK 357185A DK 357185 A DK357185 A DK 357185A
Authority
DK
Denmark
Prior art keywords
procedure
cancer diagnosis
diagnosis
cancer
Prior art date
Application number
DK357185A
Other languages
English (en)
Other versions
DK169156B1 (da
DK357185D0 (da
Inventor
Tatsuya Ishiguro
Original Assignee
Kyowa Medex Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Medex Co Ltd filed Critical Kyowa Medex Co Ltd
Publication of DK357185D0 publication Critical patent/DK357185D0/da
Publication of DK357185A publication Critical patent/DK357185A/da
Application granted granted Critical
Publication of DK169156B1 publication Critical patent/DK169156B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57476—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK357185A 1984-08-07 1985-08-06 Fremgangsmåde til diagnosticering af cancer DK169156B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16535184 1984-08-07
JP59165351A JPH06105257B2 (ja) 1984-08-07 1984-08-07 癌の測定用キット

Publications (3)

Publication Number Publication Date
DK357185D0 DK357185D0 (da) 1985-08-06
DK357185A true DK357185A (da) 1986-02-08
DK169156B1 DK169156B1 (da) 1994-08-29

Family

ID=15810706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK357185A DK169156B1 (da) 1984-08-07 1985-08-06 Fremgangsmåde til diagnosticering af cancer

Country Status (7)

Country Link
US (1) US4791066A (da)
EP (1) EP0171243B1 (da)
JP (1) JPH06105257B2 (da)
AU (1) AU584346B2 (da)
CA (1) CA1260388A (da)
DE (1) DE3586614T2 (da)
DK (1) DK169156B1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857457A (en) * 1986-07-24 1989-08-15 Shamsuddin Abulkalam M Screening test for large intestinal cancer
DE3900639A1 (de) * 1988-12-23 1990-06-28 Boehringer Mannheim Gmbh Verfahren zum nachweis von kohlenhydrathaltigen verbindungen und dazu geeignetes reagenz
US5137810A (en) * 1989-04-26 1992-08-11 The University Of North Carolina Method of determining the gram sign of bacteria
US5411868A (en) * 1989-10-24 1995-05-02 Board Of Regents, The University Of Texas System Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
DE69115926T2 (de) * 1990-11-30 1996-05-30 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
CA2321160A1 (en) * 1998-02-13 1999-08-19 Oxford Glycosciences (Uk) Ltd. Methods and compositions for diagnosis of hepatoma
US6150123A (en) * 1998-09-03 2000-11-21 Centre Integre De Recherches Biocliniques Sur Le Sida (Cirbs) Affinity biotinylation
GB9919597D0 (en) * 1999-08-18 1999-10-20 Oxford Glycosciences Uk Ltd Methods and compositions for diagnosis of hepatoma
US20030077603A1 (en) * 1999-08-18 2003-04-24 Parekh Rajesh Bhikhu Methods and compositions for diagnosis of hepatoma
US20040115754A1 (en) * 2002-12-11 2004-06-17 Umax Data Systems Inc. Method for establishing a long-term profile of blood sugar level aiding self-control of the same
TW200411178A (en) * 2002-12-31 2004-07-01 Veutron Corp Method for determining the resolution of blood glucose by using rising time curve
US20140274876A1 (en) * 2013-03-15 2014-09-18 Patricia Denny Caries risk test for predicting and assessing the risk of disease
TW592667B (en) * 2003-04-04 2004-06-21 Veutron Corp Method for determining the resolution of blood glucose
GB2404734A (en) * 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
US20100104572A1 (en) * 2006-11-02 2010-04-29 Sylvie Luria Methods for screening for therapeutic molecules and use of the molecules therefrom
CN101960310A (zh) * 2008-03-04 2011-01-26 味之素株式会社 癌症种类的评价方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329213A (en) * 1977-07-14 1982-05-11 Elwing Hans B Gel diffusion immunoassay including α-feto protein determination
IT1165552B (it) * 1979-01-30 1987-04-22 Otsuka Pharma Co Ltd Procedimento e corredo per determinare il livello di glicolegami associati a tumore
GB2114287B (en) * 1982-01-29 1985-10-30 Otsuka Pharma Co Ltd Process for determining tumor-associated glycolinkage

Also Published As

Publication number Publication date
EP0171243A3 (en) 1988-07-27
CA1260388A (en) 1989-09-26
DK169156B1 (da) 1994-08-29
EP0171243A2 (en) 1986-02-12
JPH06105257B2 (ja) 1994-12-21
AU4565485A (en) 1986-02-13
JPS6144355A (ja) 1986-03-04
US4791066A (en) 1988-12-13
DK357185D0 (da) 1985-08-06
DE3586614T2 (de) 1993-04-08
AU584346B2 (en) 1989-05-25
EP0171243B1 (en) 1992-09-09
DE3586614D1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
DK162647C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
ES509753A0 (es) Procedimiento de obtencion de quinazolinonas.
DK357185D0 (da) Fremgangsmaade til diagnosticering af cancer
DK474585A (da) Fremgangsmaade til mikroindkapsling
DK160829C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK156085D0 (da) Fremgangsmaade til fremstilling af acetoxyazetidinoner
ES547411A0 (es) Procedimiento de preparar compuestos triaminobencenicos yo- dados
RO85392A (ro) Procedeu pentru prepararea & haloalchilamide
FI834289A0 (fi) Medbringare foer en draganordning
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
DK161719C (da) Fremgangsmaade til elektroplettering
DK357685D0 (da) Fremgangsmaade til makrolid alkylering
ES504202A0 (es) Procedimiento de obtencion de benzhidrilpiperazinas
RO89014A (ro) Procedeu pentru obtinerea ferocromului
ES546140A0 (es) Procedimiento de preparar aminolactonas
ES525995A0 (es) Procedimiento de obtencion de piridopirimidinonas
ES555501A0 (es) Procedimiento de preparar carbazatos
ES540235A0 (es) Procedimiento de preparacion de ftalidoisoquinolinas amina- das
DK215082A (da) Fremgangsmaade til fremstilling af 2-iminotiazolidinderivater
FI850758L (fi) Foerfarande foer framstaellning av 3-metyl-7-fluor-5-nitrobenzotiofen.
DK154425C (da) Fremgangsmaade til fremstilling af carnitinchlorid
RO90403A2 (ro) Procedeu pentru obtinerea hidrazodicarboxamidei
ES531764A0 (es) Procedimiento de obtencion de nuevas sulfonamidinas.
ES532242A0 (es) Procedimiento de obtencion de sulfonamidinas.
DK40284A (da) Fremgangsmaade til fremstilling af n-phosphonmethylglycin

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed